Study of AHB-171 in Chronic Hepatitis B Participants

Clinical trial NCT07617194 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07617194
Sponsor: AusperBio Therapeutics Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatitis B, Chronic

Start date: 2026-07-06
Primary completion: 2027-10-08
Enrollment: 144

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.